CBAY
Cymabay Therapeutics
CBAY
CBAY
Delisted
CBAY was delisted on the 21st of March, 2024.
27 hedge funds and large institutions have $12.7M invested in Cymabay Therapeutics in 2016 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 11 reducing their positions, and 3 closing their positions.
Holders
27
Holders Change
+1
Holders Change %
+3.85%
% of All Funds
0.72%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
4
Increased
4
Reduced
11
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
VKH
1
Virtu KCG Holdings
New York
|
$33K |
2 |
2
Goldman Sachs
New York
|
$32K |
3 |
3
Barclays
London,
United Kingdom
|
$22K |
4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$1.19M |
5 |
5
Morgan Stanley
New York
|
$3K |